[Therapy of rheumatoid arthritis with recombinant gamma interferon (rIFN-gamma)]. 1989

S Meske, and S Weber, and M Wirzberger, and H H Peter
Abtl. Rheumatologie und klinische Immunologie, Medizinische Universitätskliniken Freiburg.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Meske, and S Weber, and M Wirzberger, and H H Peter
December 1990, The Journal of investigative dermatology,
S Meske, and S Weber, and M Wirzberger, and H H Peter
March 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
S Meske, and S Weber, and M Wirzberger, and H H Peter
October 1988, Journal of biological response modifiers,
S Meske, and S Weber, and M Wirzberger, and H H Peter
January 1986, Zeitschrift fur Rheumatologie,
S Meske, and S Weber, and M Wirzberger, and H H Peter
April 1988, The Journal of rheumatology,
S Meske, and S Weber, and M Wirzberger, and H H Peter
November 1993, The Journal of rheumatology,
S Meske, and S Weber, and M Wirzberger, and H H Peter
March 1990, The Journal of rheumatology,
S Meske, and S Weber, and M Wirzberger, and H H Peter
December 1988, Fortschritte der Medizin,
S Meske, and S Weber, and M Wirzberger, and H H Peter
January 2000, Lancet (London, England),
S Meske, and S Weber, and M Wirzberger, and H H Peter
January 2000, Lancet (London, England),
Copied contents to your clipboard!